1 Williams B, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.
2 Martina B. Medikamentöse Behandlung hypertensiver Krisen. Schweiz Med Forum. 2005;5:317–21.
3 Chobanian AV, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–52.
4 van den Born BH, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5(1):37–46.
5 Marik PE, Rivera R. Hypertensive emergencies: an update. Curr Opin Crit Care. 2011;17(6):569–80.
6 Peacock WFt, et al. A systematic review of nicardipine vs labetalol for the management of hypertensive crises. Am J Emerg Med. 2012;30(6):981–93.
7 Patel KK, et al., Characteristics and Outcomes of Patients Presenting With Hypertensive Urgency in the Office Setting. JAMA Intern Med. 2016;176(7):981–8.
8 Salvetti M, et al. Acute blood pressure elevation: Therapeutic approach. Pharmacol Res. 2018;130:180–90.
9 Roger VL, et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–220.
10 Janke AT, et al. Trends in the Incidence of Hypertensive Emergencies in US Emergency Departments From 2006 to 2013. J Am Heart Assoc. 2016;5(12).
11 Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356(9227):411–7.
12 Katz JN, et al. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J. 2009;158(4):599–606 e1.
13 Guiga H, et al. Hospital and out-of-hospital mortality in 670 hypertensive emergencies and urgencies. J Clin Hypertens (Greenwich). 2017;19(11):1137–42.
14 van den Born BJ, et al. Ethnic disparities in the incidence, presentation and complications of malignant hypertension. J Hypertens. 2006;24(11):2299–304.
15 Leiba A, et al. Incidence, aetiology and mortality secondary to hypertensive emergencies in a large-scale referral centre in Israel (1991-2010). J Hum Hypertens. 2016;30(8):498–502.
16 Papadopoulos DP, et al. Cardiovascular hypertensive emergencies. Curr Hypertens Rep. 2015;17(2):5.
17 Aronow WS. Treatment of hypertensive emergencies. Ann Transl Med. 2017;5(Suppl 1):S5.
18 Peixoto AJ. Acute Severe Hypertension. N Engl J Med. 2019;381(19):1843–52.
19 Ault MJ, Ellrodt AG. Pathophysiological events leading to the end-organ effects of acute hypertension. Am J Emerg Med. 1985;3(6, Suppl):10–5.
20 Mohring J, et al. Effects of saline drinking on malignant course of renal hypertension in rats. Am J Physiol. 1976;230(3):849–57.
21 De Gaudio AR, et al. Acute severe arterial hypertension: therapeutic options. Curr Drug Targets. 2009;10(8):788–98.
22 Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs. 2008;68(3):283–97.
23 Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138(17):e426–83.
24 Muiesan ML, et al. An update on hypertensive emergencies and urgencies. J Cardiovasc Med (Hagerstown). 2015;16(5):372–82.
25 Hinchey J, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494–500.
26 Roffi M, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315.
27 Erbel R, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(41):2873–926.
28 Perez MI, Musini VM. Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review. J Hum Hypertens. 2008;22(9):596–607.
29 Levy PD, et al. Blood pressure treatment and outcomes in hypertensive patients without acute target organ damage: a retrospective cohort. Am J Emerg Med. 2015;33(9):1219–24.
30 Breu AC, Axon RN. Acute Treatment of Hypertensive Urgency. J Hosp Med. 2018;13(12):860–2.
31 Rhoney D, Peacock WF. Intravenous therapy for hypertensive emergencies, part 1. Am J Health Syst Pharm. 2009;66(15):1343–52.
32 Butcher K, et al. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke. 2010;41(1):72–7.
33 Powers WJ, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–110.
34 Adams HP, Jr, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(5):1655–711.
35 European Stroke Organisation Executive. C. and E.S.O.W. Committee, Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25(5):457–507.
36 Qureshi AI, et al. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med. 2016;375(11):1033–43.
37 Cotter G, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet. 1998;351(9100):389–93.
38 Ponikowski P, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.
39 Kozhuharov N, et al. Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure: The GALACTIC Randomized Clinical Trial. JAMA. 2019;322(23):2292–302.
40 Li JZ, Eagle KA, Vaishnava P. Hypertensive and acute aortic syndromes. Cardiol Clin. 2013;31(4):493–501. [vii.].
41 Zuber SM, Kantorovich V, Pacak K. Hypertension in pheochromocytoma: characteristics and treatment. Endocrinol Metab Clin North Am. 2011;40(2):295–311. [vii.].
42 Deeks ED, Keating GM, Keam SJ. Clevidipine: a review of its use in the management of acute hypertension. Am J Cardiovasc Drugs. 2009;9(2):117–34.
43 Aronson S, et al. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008;107(4):1110–21.
44 Pollack CV, et al. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med. 2009;53(3):329–38.
45 Padilla Ramos A, Varon J. Current and newer agents for hypertensive emergencies. Curr Hypertens Rep. 2014;16(7):450.
46 Peacock WF, et al. Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO). Am Heart J. 2014;167(4):529–36.
47 Espina IM, Varon J. Clevidipine: a state-of-the-art antihypertensive drug under the scope. Expert Opin Pharmacother. 2012;13(3):387–93.
48 Short JH, et al. Clevidipine-Induced Extreme Hypoxemia in a Neurosurgical Patient: A Case Report. A A Pract. 2020;14(2):60–2.
49 Bopp C, et al. Urapidil, but not dihydropyridine calcium channel inhibitors, preserves the hypoxic pulmonary vasoconstriction: an experimental study in pig arteries. Fundam Clin Pharmacol. 2019;33(5):527–34.
50 Durrer JD, et al. Effect of sodium nitroprusside on mortality in acute myocardial infarction. N Engl J Med. 1982;306(19):1121–8.
51 Alshami A, et al. Management of hypertensive crises in the elderly. J Geriatr Cardiol. 2018;15(7):504–12.
52 Graffagnino C, et al. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial. Cerebrovasc Dis. 2013;36(3):173–80.
53 Preston RA, et al. Outcomes of minority patients with very severe hypertension (>220/>120 mmHg). J Hypertens. 2019;37(2):415–25.
1 Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, et al.; Authors/Task Force Members. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018.;36(10):1953–2041.
8 Salvetti M, Paini A, Bertacchini F, Stassaldi D, Aggiusti C, Agabiti Rosei C, Muiesan ML. Acute blood pressure elevation: Therapeutic approach. Pharmacol Res. 2018;130:180-90.
18 Peixoto AJ. Acute Severe Hypertension. N Engl J Med. 2019;381(19):1843–52.